Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00714428 · ClinicalTrials.gov registry record

Development of Quality of Life Tool for TBI

A clinical trial, sponsored by US Department of Veterans Affairs.

Completed
Registry status
485
Enrollment target

NCT00714428: Completed study, sponsored by US Department of Veterans Affairs.

NCT00714428 is a clinical trial that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 485 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00714428 has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
485 participants
Enrollment target

Study Summary

Objectives: The ultimate goal of this research program is to promote seamless, comprehensive care for Operation Enduring Freedom/ Operation Iraqi Freedom (OEF/OIF) veterans. The purpose of this study is to develop a psychometrically sound tool to measure health-related quality of life (HRQOL) applicable to wounded warriors with TBI (deployment-related TBI).

Trial Details

FieldValue
Enrollment Target 485 participants
Start Date 2009-04
Est. Completion 2012-09
US Department of Veterans Affairs

632 total trials

What the finished NCT00714428 record still lists

NCT00714428 is an observational study that tracks outcomes without assigning an intervention. The registered 485 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00714428 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00714428 about?

NCT00714428 is a clinical study titled "Development of Quality of Life Tool for TBI". Objectives: The ultimate goal of this research program is to promote seamless, comprehensive care for Operation Enduring Freedom/ Operation Iraqi Freedom (OEF/OIF) veterans. The purpose of this study is to develop a psychometrically sound tool to measure health-related quality of life (HRQOL) applic...

What is the current status of trial NCT00714428?

This trial is currently completed. The enrollment target is 485 participants. The study started on 2009-04. Estimated completion is 2012-09.

Who is sponsoring clinical trial NCT00714428?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07124910 · 485 participants · Phase 3

    Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases

  • NCT06420531 · 486 participants · NA

    Milk And Growth In Children (MAGIC) Born Very Preterm: A Randomized Trial

  • NCT07097142 · 486 participants · Phase 3

    Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

  • NCT05421741 · 484 participants · Phase 4

    Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00714428, the US trial registry maintained by the National Library of Medicine. NCT00714428 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.